1. Altman, D. G. (1998). Confidence intervals for the number needed to treat, British Medical Journal. 317, 1309–1312.
2. Altman, D. G., and Bland, J. M. (1995). Statistics notes: Absence of evidence is not evidence of absence, British Medical Journal, 311, 485.
3. Bender, S., Grohmann, R., Engel, R. R., Degner, D., Dittmann-Balcar, A., and Ruther, E. (2004). Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics, Pharmacopsychiatry, 37, S46–S53.
4. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., and Hochberg, M. C. (2000). Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid arthritis, New England Journal of Medicine, 343, 1520–1528.
5. Chuang-Stein, C., and Le, V. (2001). Recent advancements in the analysis and presentation of safety data, Drug Information Journal, 35, 377–397.